Latest S-1 registration statements

FS Credit Real Estate Income Trust, Inc. has launched a new $2.5 billion public offering, reporting positive total returns in 90 out of 92 months and a diversified $10.8 billion asset portfolio.

Aptevo Therapeutics Inc. filed an S-1 registration statement for the resale of up to 6.9 million common shares by YA II PN, LTD., part of a $25 million standby equity purchase agreement to fund its clinical-stage biotechnology pipeline.

Amaze Holdings, Inc. filed an S-1 registration statement for the resale of up to 5,524,316 shares of common stock by selling stockholders, convertible from senior secured original issue discount promissory notes.

DMINT, Inc. filed Amendment No. 5 to its S-1 registration statement for a spin-off from OLB Group, Inc., revealing substantial doubt about its ability to continue as a going concern and plans for a $16 million capital raise for expansion.

Palatin Technologies, Inc. filed an Amendment No. 1 to its S-1 registration statement, primarily to include an executed auditor consent from KPMG LLP, with no new securities being registered.

Palisade Bio, Inc. filed an S-1MEF registration statement to offer up to $24.5 million in common stock and warrants to fund its operations.

Alaska Silver Corp. filed an S-1MEF to increase its public offering by an additional $5.888 million, including subordinate voting shares and warrants.

Evolution Global Acquisition Corp, a blank check company, filed an S-1/A for a $175 million IPO targeting the critical minerals sector, with units priced at $10.00.

Bitcoin Infrastructure Acquisition Corp Ltd., a SPAC focused on digital asset infrastructure, filed an amended S-1 registration statement for its initial public offering of 20 million units at $10.00 each.

Palatin Technologies, Inc. announced a public offering of common stock and warrants to raise capital, while facing significant financial challenges and NYSE American delisting proceedings.

Fermi Inc. is launching an initial public offering to fund Project Matador, a multi-gigawatt energy and data center campus in Texas, aiming to deliver 1.1 GW by late 2026.

Aspira Women's Health Inc. filed an S-1 registration statement for the resale of 29,226,527 shares of common stock by existing selling stockholders, originating from convertible notes and warrants.

Future Fintech Group Inc. filed an S-1 registration statement for the resale of up to 20,105,000 shares of common stock by selling stockholders, potentially raising an additional $10 million from Avondale Capital.

Angel Studios, Inc. filed a pre-effective amendment to convert its S-1 registration statement to Form S-3, enabling selling securityholders to resell up to 10,042,523 shares of common stock.

Hillhouse Frontier Holdings Inc. filed an S-1/A for its initial public offering of 1.25 million Class A common shares, aiming to raise capital for expansion and diversification into car subscription services amidst declining revenue and net income in H1 2025.

BoluoC Acquisition Corp, a Cayman Islands blank check company, filed an amended S-1 registration statement for an initial public offering of 6 million units at $10.00 each, aiming to raise $60 million for a business combination within 18 to 21 months.

DevvStream Corp. files an S-1/A for the resale of up to 1,295,001 common shares by a selling stockholder, detailing its new crypto treasury strategy and ongoing carbon credit operations.

Safe and Green Development Corporation is offering up to 320,000 shares of Series B Non-Voting Convertible Preferred Stock to raise approximately $7 million for debt repayment, equipment, and property improvements.

Super League Enterprise, Inc. filed an S-1/A registration statement for the resale of up to 4,381,633 shares of common stock, including shares from a $20 million equity purchase agreement, which could lead to substantial shareholder dilution.

Phoenix Education Partners, a leading online education provider, is launching its initial public offering of 4.25 million shares, with a target price between $31.00 and $33.00 per share, but will not receive any proceeds from the sale.

GigCapital8 Corp., a new blank check company, filed an S-1/A for a $220 million initial public offering targeting aerospace, defense, cybersecurity, AI, and machine-learning sectors.

Lion Copper and Gold Corp. has filed an S-1 registration statement to allow certain selling shareholders to resell up to 194.39 million common shares, including those underlying outstanding warrants.

FreeCast, Inc. files Amendment No. 8 to its S-1 registration statement for a direct listing on the Nasdaq Global Market, aiming to register 19.78 million Class A common shares for resale by existing shareholders, despite recurring losses and a going concern warning.

Miluna Acquisition Corp, a blank check company, filed an S-1/A for its initial public offering of $60 million, seeking a business combination within 18 to 21 months, excluding PRC-based targets.

La Rosa Holdings Corp. has amended its equity purchase facility with SZOP Opportunities I LLC, increasing the potential capital raise to $1.0 billion through the sale of common stock.

Aptera Motors Corp. filed an S-1/A amendment to include an auditor's consent, which highlights substantial doubt about the company's ability to continue as a going concern.

Rent the Runway, Inc. announces a transferable rights offering to raise up to $12.5 million, backed by an investor group, as part of a broader recapitalization plan to address substantial debt.

Sonim Technologies filed an S-1 registration statement for the resale of up to 350 million common shares by Chardan Capital Markets, linked to a new $500 million committed equity facility and a pending asset sale.

Glucotrack, Inc. has entered into a $20 million committed equity financing agreement with Sixth Borough Capital Fund, LP, while progressing its implantable continuous blood glucose monitor through human trials and addressing Nasdaq listing compliance.

Medicus Pharma Ltd. filed an S-1 registration statement for the resale of up to 1,397,184 common shares by selling shareholders following its acquisition of Antev Limited and its Teverelix drug candidate.